Related Experiment Video
Updated: Feb 10, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23
1Department of Orthopedic, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, Shandong, China. tfi82987@126.com.
Objective:
Osteosarcoma is the most frequent primary bone malignancy that affects young adults and adolescents around the world. Increasing evidence suggests that dysfunctions of microRNAs (miRNAs) used to play an important role in human cancers. We aimed at evaluating the potential function of miR-16 and verify its influence on the function of RAB23 in osteosarcoma.
Patients And Methods:
miR-16 expressions in osteosarcoma tissues and cell lines were examined using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). Transwell chambers were conducted to detect the miR-16 effects on osteosarcoma cells migration and invasion. Meanwhile, Western blot and luciferase assays were performed to validate RAB23 as miR-16 targets.
Results:
miR-16 was down-regulated in osteosarcoma cell lines (MG63, SAOS-2, U2OS, and SOSP-9607) and osteosarcoma specimens, while RAB23 expression was higher in tumor tissues. Ectopic over-expression of miR-216 in osteosarcoma cells could inhibit cells migration and invasion. RAB23 was confirmed as a direct target of miR-16 and the inverse relationship between them was also observed. Over-expression of RAB23 ablates the inhibitory effects of miR-16.
Conclusions:
miR-16 inhibited cancer migration and invasion, and promoted the RAB23 expression in osteosarcoma. This newly identified miR-16/RAB23 axis may provide new insight into the pathogenesis and represents a potential therapeutic target for osteosarcoma.
Insights
MicroRNA-16 (miR-16) is down-regulated in osteosarcoma, inhibiting cancer cell migration and invasion. This study identifies a new miR-16/RAB23 pathway potentially useful for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is a prevalent bone cancer in adolescents and young adults.
- MicroRNAs (miRNAs) are increasingly recognized for their role in cancer development.
- Dysregulation of miRNAs is implicated in various human cancers, including osteosarcoma.
Purpose of the Study:
- To investigate the role of miR-16 in osteosarcoma.
- To determine the influence of miR-16 on RAB23 expression and function.
- To explore the potential of the miR-16/RAB23 axis as a therapeutic target.
Main Methods:
- Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) to measure miR-16 expression.
- Transwell assays to assess cell migration and invasion.
- Western blot and luciferase assays to validate RAB23 as a direct target of miR-16.
Main Results:
- miR-16 was found to be down-regulated in osteosarcoma tissues and cell lines.
- RAB23 expression was inversely correlated with miR-16 levels in tumor tissues.
- Overexpression of miR-16 inhibited osteosarcoma cell migration and invasion.
- RAB23 was confirmed as a direct target of miR-16, and its overexpression counteracted miR-16's inhibitory effects.
Conclusions:
- miR-16 plays an inhibitory role in osteosarcoma cell migration and invasion.
- The miR-16/RAB23 interaction represents a novel axis in osteosarcoma pathogenesis.
- This axis offers potential as a therapeutic target for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Cattell's 16 Personality Factors
In contrast, source traits are the...
Feedback Inhibition
Migration
Enzyme Inhibition

